These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 33132254)
21. Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine. Deyama S; Bang E; Wohleb ES; Li XY; Kato T; Gerhard DM; Dutheil S; Dwyer JM; Taylor SR; Picciotto MR; Duman RS Am J Psychiatry; 2019 May; 176(5):388-400. PubMed ID: 30606046 [TBL] [Abstract][Full Text] [Related]
22. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor. Deyama S; Bang E; Kato T; Li XY; Duman RS Biol Psychiatry; 2019 Jul; 86(2):143-152. PubMed ID: 30712809 [TBL] [Abstract][Full Text] [Related]
23. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms. Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812 [TBL] [Abstract][Full Text] [Related]
24. The role of eEF2 kinase in the rapid antidepressant actions of ketamine. Suzuki K; Monteggia LM Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215 [TBL] [Abstract][Full Text] [Related]
25. BDNF release and signaling are required for the antidepressant actions of GLYX-13. Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848 [TBL] [Abstract][Full Text] [Related]
26. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants. Duman RS; Deyama S; Fogaça MV Eur J Neurosci; 2021 Jan; 53(1):126-139. PubMed ID: 31811669 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Gideons ES; Kavalali ET; Monteggia LM Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of ketamine and its metabolites as antidepressants. Hess EM; Riggs LM; Michaelides M; Gould TD Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492 [TBL] [Abstract][Full Text] [Related]
29. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355 [TBL] [Abstract][Full Text] [Related]
30. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641 [TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Hashimoto K Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141 [TBL] [Abstract][Full Text] [Related]
33. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619 [TBL] [Abstract][Full Text] [Related]
34. mGlu2/3 receptor as a novel target for rapid acting antidepressants. Chaki S Adv Pharmacol; 2020; 89():289-309. PubMed ID: 32616210 [TBL] [Abstract][Full Text] [Related]
35. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Yang C; Shirayama Y; Zhang JC; Ren Q; Yao W; Ma M; Dong C; Hashimoto K Transl Psychiatry; 2015 Sep; 5(9):e632. PubMed ID: 26327690 [TBL] [Abstract][Full Text] [Related]
36. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action. Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165 [TBL] [Abstract][Full Text] [Related]
37. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats. Suzuki A; Murakami K; Tajima Y; Hara H; Kunugi A; Kimura H Pharmacol Biochem Behav; 2019 Aug; 183():80-86. PubMed ID: 31202810 [TBL] [Abstract][Full Text] [Related]
38. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761 [TBL] [Abstract][Full Text] [Related]
39. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772 [TBL] [Abstract][Full Text] [Related]
40. Decreased efficacy of the ketamine and scopolamine-induced sustained antidepressant-like effects in rats receiving metformin. Chuang HW; Wei IH; Li CT; Huang CC Pharmacol Rep; 2022 Apr; 74(2):340-352. PubMed ID: 34850372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]